LTFS
AVDL

Ladenburg Thalmann Financial Services’s Avadel Pharmaceuticals AVDL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-46
Closed – – 5147
2018
Q2 		$0 Hold
46
– – ﹤0.01% 5096
2018
Q1 		$0 Hold
46
– – ﹤0.01% 5104
2017
Q4 		$0 Sell
46
-167
-78% -$1.57K ﹤0.01% 5024
2017
Q3 		$2K Sell
213
-410
-66% -$3.92K ﹤0.01% 4642
2017
Q2 		$7K Buy
623
+2
+0.3% +$20 ﹤0.01% 4179
2017
Q1 		$6K Buy
621
+162
+35% +$1.62K ﹤0.01% 4213
2016
Q4 		$5K Sell
459
-230
-33% -$2.53K ﹤0.01% 4206
2016
Q3 		$9K Hold
689
– – ﹤0.01% 3861
2016
Q2 		$7K Sell
689
-1,752
-72% -$18.7K ﹤0.01% 3936
2016
Q1 		$27K Buy
2,441
+342
+16% +$3.4K ﹤0.01% 3035
2015
Q4 		$26K Buy
2,099
+408
+24% +$6.36K ﹤0.01% 3025
2015
Q3 		$28K Buy
1,691
+51
+3% +$1.12K ﹤0.01% 2870
2015
Q2 		$35K Buy
1,640
+525
+47% +$9.41K ﹤0.01% 2831
2015
Q1 		$20K Hold
1,115
– – ﹤0.01% 3175
2014
Q4 		$19K Sell
1,115
-295
-21% -$4.21K ﹤0.01% 3009
2014
Q3 		$20K Hold
1,410
– – ﹤0.01% 2660
2014
Q2 		$21K Hold
1,410
– – ﹤0.01% 2621
2014
Q1 		$19K Hold
1,410
– – ﹤0.01% 2602
2013
Q4 		$11K Buy
+1,410
New +$9.95K ﹤0.01% 2867

Other funds holding AVDL

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AVDL Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of Avadel Pharmaceuticals (AVDL) in Q3 2018, closing a stake of 46 shares.

Ladenburg Thalmann Financial Services first reported a position in AVDL in Q4 2013 and held it in 19 quarters. The position peaked at $35K in Q2 2015. 65 funds tracked by Wall St. Rank hold AVDL as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Avadel Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 46 Avadel Pharmaceuticals shares in Q3 2018.
  • Ladenburg Thalmann Financial Services first reported a position in Avadel Pharmaceuticals in Q4 2013 and held it in 19 quarters.
  • Ladenburg Thalmann Financial Services's Avadel Pharmaceuticals position peaked at $35K in Q2 2015.
  • 65 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.